1[1]Barton BM. Gemcitabine: a pharmacologic and clinical overview [J]. Ca ncer,1999,22(2):176.
2[2]Kelly K. The role of single-agent gemcitabine in the treatment of non-sma ll-cell lung cancer[J]. Ann Oncol,1999,10(Suppl 5):S53-56.
3[3]Van Moorsel CJ, Pinedo HM, Veerman G, et al. Mechanisms of synergism betw een cisplatin and gemcitabine in ovarian and non-small cell lung cancer cell lin es[J]. Br J Cancer,1999,80(7):981-990.
4[4]Johnson DH. Gemcitabine for the treatment of non-small-cell lung cancer[ J]. Oncology (Huntingt),2001,15(Suppl 6):33-39.
5[5]Comella P. Phase Ⅲ trial of cisplatin/gemcitabine with or without vinore lbine or paclitaxel in advanced non-small cell lung cancer[J]. Semin Oncol, 2001,28(Suppl 7):7-10.
6[6]Natale RB. Gemcitabine and nonplatinum combinations in non-small-cell lun g cancer[J]. Oncology (Huntingt),2001,15(Suppl 6):18-25.
7[7]Baron F, Cueva J, Grana B, et al. Gemcitabine plus vinorelbine for the tr eatment of advanced non-small cell lung cancer[J]. Eur J Cancer,2001,37(11):1381-1384.
8[8]Manegold C. Treatment of elderly patients with non-small-cell lung cancer [J]. Oncology (Huntingt),2001,15(Suppl 6):46-51.
9[9]Sacristan JA, Kennedy-Martin T, Rosell R, et al. Economic evaluation in a randomized phase Ⅲ clinical trial comparing gemcitabine/cisplatin and etoposid e/cisplatin in non-small cell lung cancer[J]. Lung Cancer,2000,28(2):97-107.
10Non - small cell lung cancer Co - operative Group. Chemotherapy in non - small cell lung cancer : a meta - analysis. Using up - dated data on individual patient from 52 randomized trials [ J ]. Br Med J,1995,31:899 -909.
